Clinical trial / 2008
Ginkgo biloba extract did not reduce the incidence of all-cause dementia or Alzheimer disease in elderly individuals.
A randomized, double-blind, placebo-controlled trial evaluated whether 120 mg of Ginkgo biloba extract twice daily reduced incident dementia compared to placebo over a median follow-up of 6.1 years. Overall, 523 participants developed dementia (277 in the G. biloba group and 246 in the placebo group). The hazard ratio for G. biloba compared with placebo was 1.12 (95% CI, 0.94-1.33; P = .21) for all-cause dementia and 1.16 (95% CI, 0.97-1.39; P = .11) for Alzheimer disease. G. biloba also did not alter progression to dementia in participants with mild cognitive impairment (HR, 1.13; 95% CI, 0.85-1.50; P = .39).
- Study type
- Randomized, double-blind, placebo-controlled clinical trial
- Who was studied
- 3,069 community volunteers aged 75 years or older with normal cognition (n=2,587) or mild cognitive impairment (n=482)
- What was measured
- Incident all-cause dementia and Alzheimer disease (AD)
THE PAPER
Ginkgo biloba for prevention of dementia: a randomized controlled trial.
DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, Ginkgo Evaluation of Memory (GEM) Study Investigators. JAMA, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.